RNA | MedPath

Found 453 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "RNA"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease

Conditions: COVID
Conjunctivitis

Interventions: Diagnostic Test: Schirmer Test I

First Posted Date: 2020-04-15

Last Posted Date: 2020-04-20

Lead Sponsor: G. d'Annunzio University

Target Recruit Count: 25

Registration Number: NCT04346160

Locations: 🇮🇹
Ophtalmology Clinic, G.d'Annunzio University, Chieti, Italy

IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma

Phase 1

Conditions: Melanoma, Uveal Metastatic

Interventions: Biological: Vaccination with IKKb matured Dendritic Cells

First Posted Date: 2020-04-07

Last Posted Date: 2022-03-17

Lead Sponsor: Hasumi International Research Foundation

Target Recruit Count: 12

Registration Number: NCT04335890

Locations: 🇩🇪
University Hospital Erlangen Dept. of Dermatology, Erlangen, Bavaria, Germany

Rapid HCV RNA Testing and LInkage to Care

Not Applicable

Terminated

Conditions: Hepatitis C, Chronic

Interventions: Other: HCV RNA screening

First Posted Date: 2020-03-10

Last Posted Date: 2024-01-25

Lead Sponsor: University of New Mexico

Target Recruit Count: 31

Registration Number: NCT04302948

Locations: 🇺🇸
Albuquerque HealthCare for the Homeless, Albuquerque, New Mexico, United States
🇺🇸
University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States

Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas

Early Phase 1

Withdrawn

Conditions: Malignant Melanoma

Interventions: Drug: Fluvastatin
Other: RNA-sequencing
Other: Gene expression profiling

First Posted Date: 2020-02-26

Last Posted Date: 2020-07-27

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT04285749

Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients

Conditions: Colorectal Cancer

Interventions: Diagnostic Test: CCAT1

First Posted Date: 2020-02-17

Last Posted Date: 2020-07-08

Lead Sponsor: Assiut University

Target Recruit Count: 100

Registration Number: NCT04269746

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Phase 2

Recruiting

Conditions: Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Skin Cancer
Lung Cancer
Gynecologic Cancer
Head and Neck Cancer
Sarcoma
Unknown Primary Tumors

Interventions: Drug: Atezolizumab

First Posted Date: 2020-02-17

Last Posted Date: 2024-08-21

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 200

Registration Number: NCT04273061

Locations: 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
🇨🇦
University Health Network / Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Truenat™ HCV RNA Assay Evaluation

Not Applicable

Completed

Conditions: Hepatitis C

Interventions: Device: Molbio Truenat™ HCV assay (the investigational product)
Other: Abbott RealTime HCV assay

First Posted Date: 2020-01-22

Last Posted Date: 2021-07-26

Lead Sponsor: Foundation for Innovative New Diagnostics, Switzerland

Target Recruit Count: 1330

Registration Number: NCT04236973

Locations: 🇩🇰
Aarhus University Hospital, Aarhus, Denmark
🇬🇪
National Centre for Diseases Control, Tbilisi, Georgia
🇺🇦
International Charitable Foundation Alliance for Public Health, Kyiv, Ukraine

and more 2 locations

Circulating Non-coding RNA in Acute Ischemic Stroke with Endovascular Treatment (EVTRNA)